# Immuron Ltd: Form 20-F for the period ended Jun 30, 2024

- Company: [Immuron Ltd](/companies/imrn.md) (CIK 1660046)
- Form: 20-F
- Filed: 2024-10-01
- Accepted by EDGAR: Oct 1, 2024, 08:00 ET
- Period: 2024-06-30
- Accession: 0001213900-24-083654
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1660046/000121390024083654/ea0215080-20f_immuron.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1660046/000121390024083654/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2024-06-30.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Net income | 12 months, 2023-07-01 to 2024-06-30 | −AUD 6.9m | ifrs-full:ProfitLossAttributableToOwnersOfParent |
| Cash and equivalents | at 2024-06-30 | $2.7m | ifrs-full:CashAndCashEquivalents |
| Shares outstanding | at 2024-06-30 | 227,998,346 shares | dei:EntityCommonStockSharesOutstanding |

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1660046/000121390024083654/ea0215080-20f_immuron.htm

Filed Oct 1, 2024.
Source: SEC EDGAR, the filing index for accession 0001213900-24-083654. Last ingested by Listed: Nov 10, 2026, 17:05 ET. No prices; not investment advice.
